ATE461452T1 - Verfahren zum nachweis von menschlichem parvovirus-antigen - Google Patents

Verfahren zum nachweis von menschlichem parvovirus-antigen

Info

Publication number
ATE461452T1
ATE461452T1 AT06821550T AT06821550T ATE461452T1 AT E461452 T1 ATE461452 T1 AT E461452T1 AT 06821550 T AT06821550 T AT 06821550T AT 06821550 T AT06821550 T AT 06821550T AT E461452 T1 ATE461452 T1 AT E461452T1
Authority
AT
Austria
Prior art keywords
antigen
detecting human
human parvovirus
measurement
parvovirus antigen
Prior art date
Application number
AT06821550T
Other languages
English (en)
Inventor
Mary Bernadette Butler
Amanda Marie Corcoran
Ian Gordon Elliot
Shane Kerr
Cormac Gerard Kilty
Original Assignee
Biotrin Intellectual Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotrin Intellectual Pty Ltd filed Critical Biotrin Intellectual Pty Ltd
Application granted granted Critical
Publication of ATE461452T1 publication Critical patent/ATE461452T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/015Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT06821550T 2006-12-15 2006-12-15 Verfahren zum nachweis von menschlichem parvovirus-antigen ATE461452T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IE2006/000141 WO2008072216A1 (en) 2006-12-15 2006-12-15 A method for detecting human parvovirus antigen

Publications (1)

Publication Number Publication Date
ATE461452T1 true ATE461452T1 (de) 2010-04-15

Family

ID=37903609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06821550T ATE461452T1 (de) 2006-12-15 2006-12-15 Verfahren zum nachweis von menschlichem parvovirus-antigen

Country Status (8)

Country Link
US (1) US20100105069A1 (de)
EP (1) EP2095126B1 (de)
JP (1) JP2010513865A (de)
AT (1) ATE461452T1 (de)
CA (1) CA2671474C (de)
DE (1) DE602006013053D1 (de)
DK (1) DK2095126T3 (de)
WO (1) WO2008072216A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012117382A1 (en) * 2011-03-03 2012-09-07 Novartis Ag Method for detecting parvovirus antigen
EP3130922A1 (de) 2015-08-11 2017-02-15 Roche Diagnostics GmbH Alkalische vorbehandlung von parvoviren für immunoassays
JP6808178B2 (ja) * 2015-10-15 2021-01-06 富士レビオ株式会社 ヒトパルボウイルスb19抗原および抗体の同時検出方法及びキット

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002839C (en) * 1988-11-14 2000-10-10 Neal S. Young Parvovirus capsids
JPH0910000A (ja) * 1995-06-26 1997-01-14 Nippon Sekijiyuujishiya ヒトパルボウイルスの検出方法及びそのための試薬
JP4449171B2 (ja) * 2000-06-05 2010-04-14 富士レビオ株式会社 ヒトパルボウイルスb19抗原の免疫測定方法
JP2003066047A (ja) * 2001-06-14 2003-03-05 Matsushita Electric Ind Co Ltd 免疫反応測定方法及びそれに用いる免疫反応測定用試薬

Also Published As

Publication number Publication date
US20100105069A1 (en) 2010-04-29
JP2010513865A (ja) 2010-04-30
WO2008072216A1 (en) 2008-06-19
EP2095126B1 (de) 2010-03-17
DE602006013053D1 (de) 2010-04-29
DK2095126T3 (da) 2010-05-10
EP2095126A1 (de) 2009-09-02
CA2671474C (en) 2012-09-04
CA2671474A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
ATE549624T1 (de) Verfahren und zusammensetzungen zur diagnose und behandlung von grippe
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
EP3750916A3 (de) Monoklonale antikörper gegen das denguevirus-ns1-protein
TW200512457A (en) Method of diagnosing SARS corona virus infection
DE60228557D1 (de) Candida-nachweis
WO2013009703A3 (en) Antibodies, kit and method for detecting amyloid beta oligomers
ATE442590T1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen kírperflüssigkeiten
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
DE60326336D1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
DE60318987D1 (de) Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen
ATE489632T1 (de) Antigennachweis
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
ATE461452T1 (de) Verfahren zum nachweis von menschlichem parvovirus-antigen
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
HK1123358A1 (en) Detection of circulating endothelial cells
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
WO2018172337A8 (en) IMMUNOASSAY FOR THE DETECTION OF ZIKA VIRUS INFECTION
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties